NABI /DE/
10-Q, EX-27, 2000-08-01
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NABI /DE/, 10-Q, 2000-08-01
Next: NORTHERN STATES POWER CO /MN/, U-1/A, 2000-08-01



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET (UNAUDITED) AT JULY 1, 2000 AND THE CONSOLIDATED
STATEMENT OF OPERATIONS (UNAUDITED) FOR THE SIX MONTHS ENDED JULY 1, 2000
AND IS QUALIFIED IN ITS  ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.

</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUL-01-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           1,586
<SECURITIES>                                         0
<RECEIVABLES>                                   32,109<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                     33,425<F1>
<CURRENT-ASSETS>                                74,007
<PP&E>                                         114,810<F1>
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 214,418
<CURRENT-LIABILITIES>                           34,557
<BONDS>                                        114,574
                                0
                                          0
<COMMON>                                         3,599
<OTHER-SE>                                      61,373
<TOTAL-LIABILITY-AND-EQUITY>                   214,418
<SALES>                                        113,421
<TOTAL-REVENUES>                               113,421
<CGS>                                           78,350
<TOTAL-COSTS>                                   78,350
<OTHER-EXPENSES>                                31,585
<LOSS-PROVISION>                                     0<F2>
<INTEREST-EXPENSE>                               2,005
<INCOME-PRETAX>                                  1,691
<INCOME-TAX>                                        67
<INCOME-CONTINUING>                              1,624
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                    340
<CHANGES>                                            0
<NET-INCOME>                                     1,964
<EPS-BASIC>                                        .06
<EPS-DILUTED>                                      .05

<FN>
(1) Receivables, inventory and PP&E represent net amounts
(2) Loss provision included in other expenses
</FN>

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission